Search results for covid-19

“Most pregnant women who develop COVID-19 experience mild or asymptomatic illness and rarely transmit the disease to their infants in utero or postpartum. Findings from a new study suggest that specialized "decoy" proteins in amniotic fluid and breast milk protect fetuses and newborns from severe COVID-19.”

“Children are largely unaffected by COVID-19 infection, remaining disease-free or manifesting few or mild clinical signs and symptoms. Understanding how the infection affects children is critical to preventing the further spread of the disease.”

“Findings from a new study demonstrate that the SARS-CoV-2 virus targets the cardiomyocytes of the heart in the setting of COVID-19, causing myocarditis. SARS-CoV-2, the virus that causes COVID-19, exploits the ACE2 receptor to gain entry into cells.”

“Disturbances in this system can drive poor outcomes, such as acute respiratory distress syndrome (ARDS) and death in COVID-19. Findings from a recent study suggest that supplementation with calcifediol, an intermediate molecule in the production of the active form of vitamin D, reduces the risk of death due to COVID-19.”

“No treatment or vaccine currently exists for COVID-19, the disease caused by SARS-CoV-2. Recently published data from a mouse study suggest that a laboratory-created human antibody can neutralize SARS-CoV-2 and has potential as a therapeutic agent against the disease.”

“Everlywell, a company that offers home lab tests, will begin offering at-home COVID-19 tests prescribed by a doctor based on criteria established by the CDC. About 30,000 of these at-home tests will be available beginning 3/23/20. The sample will be processed at one of several FDA-approved labs to perform the test within 72 hours and the results will be sent to patients via text and email.”

“Robust evidence indicates that SARS-CoV-2, the virus that causes COVID-19, spreads primarily via respiratory droplets in the exhaled air of infected persons. Although the wearing of face masks is a critical component of global public health strategies to prevent spread of the disease, small respiratory droplets that are less than 1 micron in diameter can pass through the masks.”

“The amount of viral replication in the early stages of infection determines transmissibility and predicts the severity of COVID-19 illness. As the number of viral particles increases, the immune system enhances the expression of interferon-stimulated genes, which are necessary for the antiviral response.”

“SARS-CoV-2, the virus that causes COVID-19, is one of the coronaviruses, a large family of viruses that typically causes mild to moderate upper-respiratory tract illnesses, like the common cold.”

“A number of randomized controlled trials are currently underway investigating various antiviral therapies for the treatment of COVID-19. Findings from a very small open-label study recently published in the Journal of Antimicrobial Agents found that hydroxychloroquine decreased viral nasopharyngeal levels of SARS-CoV-2 virus in COVID-19 patients in only three to six days in most patients.”